Podrobno

Circular RNA in hepatocellular carcinoma : emerging therapeutic strategies
ID Jazbec, Gregor (Avtor), ID Režen, Tadeja (Avtor)

.pdfPDF - Predstavitvena datoteka, prenos (2,29 MB)
MD5: C1AD91F38CCF8CED361B2626B024B656
URLURL - Izvorni URL, za dostop obiščite https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2025.1722576/full Povezava se odpre v novem oknu

Izvleček
Circular RNAs, or circRNAs, are unique single-stranded RNA molecules that form covalently closed circles. They possess a wide range of cellular functions and can act as tumor suppressors or promoters, regulating various aspects of carcinogenesis. These functions include acting as microRNA sponges, nteracting with and binding to proteins and mRNA, regulating transcription and RNA splicing, translating into proteins, and serving as cargo in exosomes. Due to their diverse cellular roles and enhanced molecular stability, circRNAs are not only promising biomarkers but also emerging candidates for the development of RNA-based therapeutics. In this review, we explored the therapeutic potential of circular RNA by reviewing the current state of the art n the field of oncology, with a particular focus on hepatocellular carcinoma. Based on their endogenous functions, circular RNA can be designed, synthesized and delivered to produce various proteins, such as neoantigens and cytokines, or to sequester oncogenic microRNA in tumor cells. Although many therapeutic applications of circular RNA are still in the early stages of development, they have already shown promising results in both in vitro and in vivo animal models. In summary, circular RNAs are emerging as both therapeutics and biomarkers in iver cancer and broader oncology, with relevant clinical applicability, particularly n immunotherapy.

Jezik:Angleški jezik
Ključne besede:RNA-based therapeutics, circRNA, circRNA-based therapeutics, hepatocellular carcinoma, immunotherapy
Vrsta gradiva:Članek v reviji
Tipologija:1.02 - Pregledni znanstveni članek
Organizacija:MF - Medicinska fakulteta
Status publikacije:Objavljeno
Različica publikacije:Objavljena publikacija
Poslano v recenzijo:20.11.2025
Datum sprejetja članka:25.11.2025
Datum objave:09.12.2025
Leto izida:2025
Št. strani:16 str.
Številčenje:Vol. 16, art. 1722576
PID:20.500.12556/RUL-177805 Povezava se odpre v novem oknu
UDK:577.2
ISSN pri članku:1664-3224
DOI:10.3389/fimmu.2025.1722576 Povezava se odpre v novem oknu
COBISS.SI-ID:263803139 Povezava se odpre v novem oknu
Datum objave v RUL:08.01.2026
Število ogledov:424
Število prenosov:222
Metapodatki:XML DC-XML DC-RDF
:
Kopiraj citat
Objavi na:Bookmark and Share

Gradivo je del revije

Naslov:Frontiers in immunology
Skrajšan naslov:Front. immunol.
Založnik:Frontiers Media
ISSN:1664-3224
COBISS.SI-ID:30774233 Povezava se odpre v novem oknu

Licence

Licenca:CC BY 4.0, Creative Commons Priznanje avtorstva 4.0 Mednarodna
Povezava:http://creativecommons.org/licenses/by/4.0/deed.sl
Opis:To je standardna licenca Creative Commons, ki daje uporabnikom največ možnosti za nadaljnjo uporabo dela, pri čemer morajo navesti avtorja.

Sekundarni jezik

Jezik:Slovenski jezik
Ključne besede:terapija na osnovi RNA, cirkularna RNA, terapija na osnovi cirkularne RNA, hepatocelularni karcinom, imunoterapija

Projekti

Financer:ARIS - Javna agencija za znanstvenoraziskovalno in inovacijsko dejavnost Republike Slovenije
Številka projekta:P1-0390
Naslov:Funkcijska genomika in biotehnologija za zdravje

Financer:ARIS - Javna agencija za znanstvenoraziskovalno in inovacijsko dejavnost Republike Slovenije
Številka projekta:I0-0022
Naslov:Mreža raziskovalnih infrastrukturnih centrov Univerze v Ljubljani (MRIC UL)

Financer:ARIS - Javna agencija za znanstvenoraziskovalno in inovacijsko dejavnost Republike Slovenije
Številka projekta:J3-4513
Naslov:Vloga in aplikativnost krožnih RNA pri raku jeter

Financer:ARIS - Javna agencija za znanstvenoraziskovalno in inovacijsko dejavnost Republike Slovenije
Program financ.:Young researchers

Podobna dela

Podobna dela v RUL:
Podobna dela v drugih slovenskih zbirkah:

Nazaj